Ownership Submission
FORM 3
 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Expires: January 31, 2005
Estimated average burden hours per response... 0.5

(Print or Type Responses)
1. Name and Address of Reporting Person *
  Nicholson Ryan
 2. Date of Event Requiring Statement (Month/Day/Year)
02/05/2019		 3. Issuer Name and Ticker or Trading Symbol
Dolby Laboratories, Inc. [DLB]
(Last)
(First)
(Middle)
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET		 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director _____ 10% Owner
__X__ Officer (give title below) _____ Other (specify below)
VP, Corporate Controller
 5. If Amendment, Date Original Filed(Month/Day/Year)
(Street)

SAN FRANCISCO, CA 94103		 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
(City)
(State)
(Zip)
Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)		 2. Amount of Securities Beneficially Owned
(Instr. 4)		 3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)		 4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Class A Common Stock 11,357 (1)
D
 

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. SEC 1473 (7-02)
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 4)		 2. Date Exercisable and Expiration Date
(Month/Day/Year)		 3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)		 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)		 6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option (Right to Buy)   (2) 12/15/2021 Class A Common Stock 395 $ 28.24 D  
Employee Stock Option (Right to Buy)   (3) 12/21/2022 Class A Common Stock 2,900 $ 30.49 D  
Employee Stock Option (Right to Buy)   (4) 12/16/2023 Class A Common Stock 3,600 $ 37.35 D  
Employee Stock Option (Right to Buy)   (5) 12/15/2024 Class A Common Stock 3,025 $ 42.98 D  
Employee Stock Option (Right to Buy)   (6) 12/15/2025 Class A Common Stock 7,000 $ 33.15 D  
Employee Stock Option (Right to Buy)   (7) 12/15/2026 Class A Common Stock 8,000 $ 45.5 D  
Employee Stock Option (Right to Buy)   (8) 12/15/2027 Class A Common Stock 12,500 $ 62.32 D  
Employee Stock Option (Right to Buy)   (9) 12/17/2028 Class A Common Stock 11,900 $ 64.6 D  
Employee Stock Option (Right to Buy)   (10) 10/17/2021 Class A Common Stock 1,740 $ 25 D  
Employee Stock Option (Right to Buy)   (11) 09/15/2025 Class A Common Stock 10,500 $ 31.73 D  

Reporting Owners

Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Nicholson Ryan
C/O DOLBY LABORATORIES, INC.
1275 MARKET STREET
SAN FRANCISCO, CA 94103		       VP, Corporate Controller  

Signatures

/s/ Daniel Rodriguez, Attorney-in-Fact for Ryan Nicholson 02/13/2019
**Signature of Reporting Person Date

Explanation of Responses:

* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1) Shares held include 6,807 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.
(2) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 15, 2011 and the balance of the shares vested in equal monthly installments over the next 36 months.
(3) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 21, 2012 and the balance of the shares vested in equal monthly installments over the next 36 months.
(4) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 16, 2013 and the balance of the shares vested in equal monthly installments over the next 36 months.
(5) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 15, 2014 and the balance of the shares vested in equal monthly installments over the next 36 months.
(6) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 15, 2015 and the balance of the shares vests in equal monthly installments over the next 36 months.
(7) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 15, 2016 and the balance of the shares vests in equal monthly installments over the next 36 months.
(8) 1/4 of the total number of shares issuable under this option vested on the first anniversary of December 15, 2017 and the balance of the shares vests in equal monthly installments over the next 36 months.
(9) 1/4 of the total number of shares issuable under this option will vest on the first anniversary of December 17, 2018 and the balance of the shares vests in equal monthly installments over the next 36 months.
(10) 1/4 of the total number of shares issuable under this option vested on the first anniversary of October 15, 2011 and the balance of the shares vested in equal monthly installments over the next 36 months.
(11) 1/4 of the total number of shares issuable under this option vested on the first anniversary of September 15, 2015 and the balance of the shares vests in equal monthly installments over the next 36 months.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, See Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.